NCT03186118View on ClinicalTrials.gov

Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 4, 2017

Primary Completion Date

September 13, 2021

Study Completion Date

July 31, 2033

Conditions
CD 19+ Acute Leukemia
Interventions
BIOLOGICAL

T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC)

Autologous CD4 and CD8 T cells transduced to express a truncated CD19 (CD19t) Transgene

Trial Locations (1)

98105

Seattle Children's Hospital, Seattle

All Listed Sponsors
lead

Seattle Children's Hospital

OTHER